High Tuberculosis Preventive Treatment Uptake and Completion Rates Using a Person-Centered Approach among Tuberculosis Household Contact in Yogyakarta

被引:0
|
作者
Felisia, Felisia [1 ]
Triasih, Rina [1 ,2 ]
Nababan, Betty Weri Yolanda [1 ]
Sanjaya, Guardian Yoki [3 ]
Dewi, Setyogati Candra [4 ]
Rahayu, Endang Sri [4 ]
Unwanah, Lana [4 ]
du Cros, Philipp [5 ]
Chan, Geoffrey [5 ]
机构
[1] Gadjah Mada Univ, Fac Med Publ Hlth & Nursing, Ctr Trop Med, Sleman 55281, Yogyakarta, Indonesia
[2] Gadjah Mada Univ, Fac Med Publ Hlth & Nursing, Dept Pediat, Sleman 55281, Yogyakarta, Indonesia
[3] Gadjah Mada Univ, Dept Hlth Policy & Management, Fac Med Publ Hlth & Nursing, Sleman 55281, Yogyakarta, Indonesia
[4] Yogyakarta City Hlth Off, Yogyakarta 55165, Yogyakarta, Indonesia
[5] Burnet Inst, TB Eliminat & Implementat Sci Working Grp, Melbourne, Vic 3004, Australia
关键词
tuberculosis preventive treatment (TPT); short regimen; person-centered care; INFECTION; RIFAPENTINE; COUNTRIES;
D O I
10.3390/tropicalmed8120520
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Coverage of tuberculosis preventive treatment (TPT) in Indonesia is inadequate, and persons who start TPT often do not complete treatment. In 2020, Zero TB Yogyakarta implemented person-centered contact investigation and shorter TPT regimen provision in collaboration with primary health care centers. Between 1 January 2020 and 31 August 2022, we assessed eligibility for TPT among household contacts of persons with bacteriologically confirmed TB (index cases) and offered them a 3-month TPT regimen (3RH or 3HP). A dedicated nurse monitored contacts on TPT for treatment adherence and side effects every week in the first month and every two weeks in the next months. Contacts were also able to contact a nurse by phone or ask for home visits at any point if they had any concerns. A total of 1016 contacts were eligible for TPT: 772 (78.8%) started short regimen TPT with 706 (91.5%) completing their TPT. Side effects were reported in 26 (39%) of the non-completion group. We conclude that high rates of TPT uptake and completion among contacts assessed as eligible for TPT can be achieved through person-centered care and the use of shorter regimens. Side-effect monitoring and management while on TPT is vital for improving TPT completion.
引用
收藏
页数:10
相关论文
共 39 条
  • [21] Situation Analysis of Early Implementation of Programmatic Management of Tuberculosis Preventive Treatment among Household Contacts of Pulmonary TB Patients in Delhi, India
    Alvi, Yasir
    Philip, Sairu
    Anand, Tanu
    Chinnakali, Palanivel
    Islam, Farzana
    Singla, Neeta
    Thekkur, Pruthu
    Khanna, Ashwani
    Vashishat, B. K.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2024, 9 (01)
  • [22] A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates
    Bishara, Hashem
    Ore, Liora
    Armaly, Najat
    Ravell, Daniel Weiler
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [23] Socioeconomic support to improve completion of tuberculosis preventive therapy among adults starting HIV treatment in Tanzania: a quasi-cluster randomized trial
    Fahey, C. A.
    Maokola, W.
    Sabasaba, A.
    Msasa, J.
    Mnyippembe, A.
    Ndungile, Y.
    McCoy, S. I.
    Njau, P. F.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26
  • [24] Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi Process
    Maggiolo, Franco
    Lo Caputo, Sergio
    Bonora, Stefano
    Borderi, Marco
    Cingolani, Antonella
    DEttorre, Gabriella
    Di Biagio, Antonio
    Di Giambenedetto, Simona
    Gervasoni, Cristina
    Guaraldi, Giovanni
    Maggi, Paolo
    Taramasso, Lucia
    NEW MICROBIOLOGICA, 2023, 46 (04): : 367 - 380
  • [25] Test and Treat Model for Tuberculosis Preventive Treatment among Household Contacts of Pulmonary Tuberculosis Patients in Selected Districts of Maharashtra: A Mixed-Methods Study on Care Cascade, Timeliness, and Early Implementation Challenges
    Mahajan, Palak
    Soundappan, Kathirvel
    Singla, Neeta
    Mehta, Kedar
    Nuken, Amenla
    Thekkur, Pruthu
    Nair, Divya
    Rattan, Sampan
    Thakur, Chaturanand
    Sachdeva, Kuldeep Singh
    Kalottee, Bharati
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2024, 9 (01)
  • [26] Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review
    Gebreegziabher, Senedu Bekele
    Ashuro, Akililu Alemu
    Kumssa, Tsegaye Hailu
    Teferi, Melese Yeshambaw
    Alemayue, Endawoke Amsalu
    Datiko, Daniel Gemechu
    Yimer, Solomon Abebe
    Shagre, Mulatu Biru
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [27] Using the Health Belief Model to PredictTuberculosis Preventive Behaviors Among Tuberculosis Patients' Household Contacts During the COVID-19 Pandemic in the Border Areas of Northern Thailand
    Khamai, Nantawan
    Seangpraw, Katekaew
    Ong-Artborirak, Parichat
    JOURNAL OF PREVENTIVE MEDICINE & PUBLIC HEALTH, 2024, 57 (03): : 223 - 233
  • [28] Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis
    Ryckman, Theresa
    Weiser, Jeff
    Gombe, Makaita
    Turner, Karin
    Soni, Priyanka
    Tarlton, Dessislava
    Mazhidova, Nargiza
    Churchyard, Gavin
    Chaisson, Richard E.
    Dowdy, David W.
    LANCET GLOBAL HEALTH, 2023, 11 (08): : E1205 - E1216
  • [29] Tuberculosis preventive treatment uptake among adults living with human immunodeficiency virus: Analysis of Zimbabwe population-based human immunodeficiency virus impact assessment 2020
    Maphosa, Talent
    Mirkovic, Kelsey
    Weber, Rachel A.
    Musuka, Godfrey
    Mapingure, Munyaradzi P.
    Ershova, Julia
    Laws, Rebecca
    Dobbs, Trudy
    Coggin, William
    Sandy, Charles
    Apollo, Tsitsi
    Mugurungi, Owen
    Melchior, Michael
    Farahani, Mansoor S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2024, 35 (08) : 593 - 599
  • [30] High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
    Romain Ragonnet
    James M. Trauer
    Justin T. Denholm
    Ben J. Marais
    Emma S. McBryde
    BMC Infectious Diseases, 17